Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: Results of the AML02 multicentre trial

Fingerprint

Dive into the research topics of 'Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: Results of the AML02 multicentre trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry